Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Oppenheimer biotech analyst to hold a reception » 17:55
06/02/23
06/02
17:55
06/02/23
17:55
AGEN

Agenus

$1.62 /

+0.025 (+1.57%)

, CGEN

Compugen

$1.04 /

+0.03 (+2.97%)

, DAWN

Day One Biopharmaceuticals

$13.60 /

-0.04 (-0.29%)

, ERAS

Erasca

$2.91 /

+0.215 (+7.99%)

, IMRX

Immuneering

$8.66 /

-0.64 (-6.88%)

, KNTE

Kinnate Biopharma

$4.22 /

-0.1 (-2.31%)

, MRTX

Mirati Therapeutics

$38.18 /

+1.12 (+3.02%)

, RVMD

Revolution Medicines

$25.54 /

+0.37 (+1.47%)

, VIRX

Viracta Therapeutics

$1.45 /

+0.05 (+3.57%)

, ONCT

Oncternal Therapeutics

/

+

, BMEA

Biomea Fusion

$35.79 /

+0.185 (+0.52%)

, MRNA

Moderna

$130.52 /

+1.99 (+1.55%)

, REGN

Regeneron

$740.00 /

+8.995 (+1.23%)

, AZN

AstraZeneca

$72.57 /

-0.27 (-0.37%)

, GILD

Gilead

$77.88 /

+1.665 (+2.18%)

, VSTM

Verastem

$11.90 /

+0.07 (+0.59%)

, SWTX

SpringsWorks Therapeutics

$27.33 /

-0.34 (-1.23%)

Biotech Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:55

Get Free Trial

ShowHide Related Items >><<
VSTM Verastem
$11.90 /

+0.07 (+0.59%)

VIRX Viracta Therapeutics
$1.45 /

+0.05 (+3.57%)

SWTX SpringsWorks Therapeutics
$27.33 /

-0.34 (-1.23%)

RVMD Revolution Medicines
$25.54 /

+0.37 (+1.47%)

REGN Regeneron
$740.00 /

+8.995 (+1.23%)

ONCT Oncternal Therapeutics
/

+

MRTX Mirati Therapeutics
$38.18 /

+1.12 (+3.02%)

MRNA Moderna
$130.52 /

+1.99 (+1.55%)

KNTE Kinnate Biopharma
$4.22 /

-0.1 (-2.31%)

IMRX Immuneering
$8.66 /

-0.64 (-6.88%)

GILD Gilead
$77.88 /

+1.665 (+2.18%)

ERAS Erasca
$2.91 /

+0.215 (+7.99%)

DAWN Day One Biopharmaceuticals
$13.60 /

-0.04 (-0.29%)

CGEN Compugen
$1.04 /

+0.03 (+2.97%)

BMEA Biomea Fusion
$35.79 /

+0.185 (+0.52%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

AGEN Agenus
$1.62 /

+0.025 (+1.57%)

AGEN Agenus
$1.62 /

+0.025 (+1.57%)

05/25/23 EF Hutton
Agenus assumed with a Buy at EF Hutton
05/09/23 H.C. Wainwright
Agenus's progress continues with data presentations, says H.C. Wainwright
04/20/23 B. Riley
B. Riley came away 'encouraged' on Agenus after AACR
02/28/23 H.C. Wainwright
Agenus assumed with a Buy at H.C. Wainwright
CGEN Compugen
$1.04 /

+0.03 (+2.97%)

02/08/23 Jefferies
Compugen downgraded to Underperform from Hold at Jefferies
01/04/23 EF Hutton
Compugen initiated with a Buy at EF Hutton
11/14/22 Oppenheimer
Compugen price target lowered to $8 from $12 at Oppenheimer
08/23/22 Truist
Compugen price target lowered to $4 from $14 at Truist
DAWN Day One Biopharmaceuticals
$13.60 /

-0.04 (-0.29%)

05/01/23 Oppenheimer
Day One language around NDA submission 'sounded ominous,' says Oppenheimer
05/01/23 H.C. Wainwright
Day One pullback brings attractive entry point, says H.C. Wainwright
04/25/23 BofA
Day One Biopharmaceuticals double downgraded at BofA on regulatory risks
04/25/23 BofA
Day One Biopharmaceuticals downgraded to Underperform from Buy at BofA
ERAS Erasca
$2.91 /

+0.215 (+7.99%)

03/29/23 Mizuho
Erasca initiated with a Buy at Mizuho
02/24/23 Goldman Sachs
Erasca initiated with a Buy at Goldman Sachs
02/03/23 Morgan Stanley
Erasca upgraded to Overweight from Equal Weight at Morgan Stanley
IMRX Immuneering
$8.66 /

-0.64 (-6.88%)

04/19/23 Mizuho
Immuneering upgraded to Buy from Neutral at Mizuho
04/19/23 Morgan Stanley
Immuneering upgraded to Equal Weight from Underweight at Morgan Stanley
04/18/23 Chardan
Immuneering price target raised to $22 from $18 at Chardan
03/29/23 Mizuho
Immuneering initiated with a Neutral at Mizuho
KNTE Kinnate Biopharma
$4.22 /

-0.1 (-2.31%)

05/18/23 H.C. Wainwright
Kinnate Biopharma price target lowered to $24 from $25 at H.C. Wainwright
04/20/23 H.C. Wainwright
Kinnate Biopharma price target lowered to $25 from $33 at H.C. Wainwright
04/18/23 Stifel
Kinnate Biopharma price target lowered to $5 from $8 at Stifel
04/18/23 Wedbush
Kinnate Biopharma price target lowered to $14 from $25 at Wedbush
MRTX Mirati Therapeutics
$38.18 /

+1.12 (+3.02%)

05/25/23 Oppenheimer
Oppenheimer upgrades Mirati to Outperform with Krazati expectations reset
05/25/23 Oppenheimer
Mirati Therapeutics upgraded to Outperform from Perform at Oppenheimer
05/25/23 BMO Capital
Mirati Therapeutics price target lowered to $40 from $50 at BMO Capital
05/25/23 Barclays
Mirati Therapeutics price target lowered to $75 from $90 at Barclays
RVMD Revolution Medicines
$25.54 /

+0.37 (+1.47%)

05/09/23 JPMorgan
Revolution Medicines price target lowered to $35 from $38 at JPMorgan
02/28/23 Needham
Revolution Medicines price target raised to $38 from $32 at Needham
02/28/23 Oppenheimer
Revolution Medicines price target raised to $35 from $30 at Oppenheimer
02/28/23 JPMorgan
Revolution Medicines upgraded to Overweight from Neutral at JPMorgan
VIRX Viracta Therapeutics
$1.45 /

+0.05 (+3.57%)

05/10/23 H.C. Wainwright
Viracta Therapeutics price target lowered to $33 from $35 at H.C. Wainwright
ONCT Oncternal Therapeutics
/

+

04/06/23 Cantor Fitzgerald
Oncternal downgraded to Neutral from Overweight at Cantor Fitzgerald
04/04/23 Maxim
Oncternal Therapeutics downgraded to Hold from Buy at Maxim
04/04/23 Cantor Fitzgerald
Oncternal Therapeutics price target lowered to $1.30 from $4.00 at Cantor Fitzgerald
04/04/23 H.C. Wainwright
Oncternal Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
BMEA Biomea Fusion
$35.79 /

+0.185 (+0.52%)

05/25/23 EF Hutton
Biomea Fusion assumed with a Buy at EF Hutton
05/18/23 Citi
Biomea Fusion price target lowered to $53 from $55 at Citi
05/12/23 Barclays
Biomea Fusion initiated with an Overweight at Barclays
04/19/23 H.C. Wainwright
Biomea Fusion price target lowered to $37 from $44 at H.C. Wainwright
MRNA Moderna
$130.52 /

+1.99 (+1.55%)

05/31/23 Jefferies
Carisma Therapeutics assumed at Buy from Hold at Jefferies
05/05/23 Morgan Stanley
Moderna price target lowered to $153 from $185 at Morgan Stanley
04/25/23 Guggenheim
Moderna initiated with a Neutral at Guggenheim
04/13/23 Baird
Carisma Therapeutics initiated with an Outperform at Baird
REGN Regeneron
$740.00 /

+8.995 (+1.23%)

05/19/23 Piper Sandler
Regeneron Q1 Eylea miss 'not about share, says Piper Sandler
05/08/23 Guggenheim
Regeneron price target lowered to $935 from $960 at Guggenheim
05/05/23 Morgan Stanley
Regeneron price target raised to $927 from $880 at Morgan Stanley
05/05/23 SVB Securities
Regeneron price target lowered to $895 from $976 at SVB Securities
AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

05/26/23 Argus
AstraZeneca price target lowered to $80 from $85 at Argus
05/09/23 Berenberg
AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg
04/28/23 JPMorgan
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan
04/13/23 Argus
AstraZeneca price target raised to $85 from $75 at Argus
GILD Gilead
$77.88 /

+1.665 (+2.18%)

06/02/23 Argus
Gilead continues to make regulatory progress, says Argus
05/16/23 BMO Capital
Gilead upgraded to Outperform from Market Perform at BMO Capital
04/28/23 Piper Sandler
Gilead assumed with an Overweight at Piper Sandler
04/12/23 Morgan Stanley
Gilead price target raised to $85 from $81 at Morgan Stanley
VSTM Verastem
$11.90 /

+0.07 (+0.59%)

05/10/23 H.C. Wainwright
Verastem price target lowered to $2 from $3 at H.C. Wainwright
03/29/23 Mizuho
Verastem initiated with a Neutral at Mizuho
11/07/22 H.C. Wainwright
Verastem price target lowered to $3 from $5 at H.C. Wainwright
10/05/22 BTIG
Verastem price target lowered to $5 from $8 at BTIG
SWTX SpringsWorks Therapeutics
$27.33 /

-0.34 (-1.23%)

04/28/23 Barclays
SpringsWorks Therapeutics price target lowered to $41 from $55 at Barclays
03/07/23 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $105 from $99 at H.C. Wainwright
01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
12/01/22 BofA
SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA
VSTM Verastem
$11.90 /

+0.07 (+0.59%)

VIRX Viracta Therapeutics
$1.45 /

+0.05 (+3.57%)

SWTX SpringsWorks Therapeutics
$27.33 /

-0.34 (-1.23%)

RVMD Revolution Medicines
$25.54 /

+0.37 (+1.47%)

REGN Regeneron
$740.00 /

+8.995 (+1.23%)

ONCT Oncternal Therapeutics
/

+

MRTX Mirati Therapeutics
$38.18 /

+1.12 (+3.02%)

MRNA Moderna
$130.52 /

+1.99 (+1.55%)

KNTE Kinnate Biopharma
$4.22 /

-0.1 (-2.31%)

GILD Gilead
$77.88 /

+1.665 (+2.18%)

ERAS Erasca
$2.91 /

+0.215 (+7.99%)

DAWN Day One Biopharmaceuticals
$13.60 /

-0.04 (-0.29%)

CGEN Compugen
$1.04 /

+0.03 (+2.97%)

BMEA Biomea Fusion
$35.79 /

+0.185 (+0.52%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

AGEN Agenus
$1.62 /

+0.025 (+1.57%)

  • 18
    Apr
  • 30
    Mar
  • 03
    Mar
  • 09
    Dec
  • 20
    Jul
  • 15
    Jun
REGN Regeneron
$740.00 /

+8.995 (+1.23%)

MRTX Mirati Therapeutics
$38.18 /

+1.12 (+3.02%)

MRNA Moderna
$130.52 /

+1.99 (+1.55%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

VSTM Verastem
$11.90 /

+0.07 (+0.59%)

SWTX SpringsWorks Therapeutics
$27.33 /

-0.34 (-1.23%)

RVMD Revolution Medicines
$25.54 /

+0.37 (+1.47%)

REGN Regeneron
$740.00 /

+8.995 (+1.23%)

ONCT Oncternal Therapeutics
/

+

MRTX Mirati Therapeutics
$38.18 /

+1.12 (+3.02%)

MRNA Moderna
$130.52 /

+1.99 (+1.55%)

KNTE Kinnate Biopharma
$4.22 /

-0.1 (-2.31%)

GILD Gilead
$77.88 /

+1.665 (+2.18%)

ERAS Erasca
$2.91 /

+0.215 (+7.99%)

DAWN Day One Biopharmaceuticals
$13.60 /

-0.04 (-0.29%)

BMEA Biomea Fusion
$35.79 /

+0.185 (+0.52%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

AGEN Agenus
$1.62 /

+0.025 (+1.57%)

REGN Regeneron
$740.00 /

+8.995 (+1.23%)

MRNA Moderna
$130.52 /

+1.99 (+1.55%)

GILD Gilead
$77.88 /

+1.665 (+2.18%)

BMEA Biomea Fusion
$35.79 /

+0.185 (+0.52%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

Conference/Events
Cantor Fitzgerald biotech analyst to hold analyst/industry conference call » 16:39
06/02/23
06/02
16:39
06/02/23
16:39
ONCY

Oncolytics

$1.70 /

+0.05 (+3.03%)

, IMAB

I-Mab

$3.18 /

+0.145 (+4.78%)

, HCM

Hutchmed

$12.47 /

+0.35 (+2.89%)

, PDSB

PDS Biotechnology

$9.40 /

-0.5 (-5.05%)

, EFTR

eFfector Therapeutics

$1.17 /

+0.13 (+12.50%)

, ARAV

Aravive

$1.80 /

+0.04 (+2.27%)

, JNJ

Johnson & Johnson

$156.98 /

+2.44 (+1.58%)

, BMY

Bristol-Myers

$65.66 /

+0.98 (+1.52%)

, REGN

Regeneron

$740.00 /

+8.995 (+1.23%)

, GILD

Gilead

$77.88 /

+1.665 (+2.18%)

, NVS

Novartis

$98.90 /

+1.79 (+1.84%)

, MBIO

Mustang Bio

$5.60 /

-0.71 (-11.25%)

Biotechnology Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:39

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$740.00 /

+8.995 (+1.23%)

PDSB PDS Biotechnology
$9.40 /

-0.5 (-5.05%)

ONCY Oncolytics
$1.70 /

+0.05 (+3.03%)

NVS Novartis
$98.90 /

+1.79 (+1.84%)

MBIO Mustang Bio
$5.60 /

-0.71 (-11.25%)

JNJ Johnson & Johnson
$156.98 /

+2.44 (+1.58%)

IMAB I-Mab
$3.18 /

+0.145 (+4.78%)

HCM Hutchmed
$12.47 /

+0.35 (+2.89%)

GILD Gilead
$77.88 /

+1.665 (+2.18%)

EFTR eFfector Therapeutics
$1.17 /

+0.13 (+12.50%)

BMY Bristol-Myers
$65.66 /

+0.98 (+1.52%)

ARAV Aravive
$1.80 /

+0.04 (+2.27%)

ONCY Oncolytics
$1.70 /

+0.05 (+3.03%)

05/23/23 JonesResearch
Oncolytics initiated with a Buy at JonesResearch
03/06/23 Canaccord
Oncolytics price target lowered to $5.00 from $6.00 at Canaccord
03/06/23 Cantor Fitzgerald
Oncolytics initiated with an Overweight at Cantor Fitzgerald
IMAB I-Mab
$3.18 /

+0.145 (+4.78%)

04/03/23 Piper Sandler
I-Mab price target lowered to $25 from $30 at Piper Sandler
04/03/23 H.C. Wainwright
I-Mab price target lowered to $25 from $45 at H.C. Wainwright
08/31/22 H.C. Wainwright
I-Mab price target lowered to $45 from $70 at H.C. Wainwright
08/30/22 Piper Sandler
I-Mab price target lowered to $30 from $35 at Piper Sandler
HCM Hutchmed
$12.47 /

+0.35 (+2.89%)

PDSB PDS Biotechnology
$9.40 /

-0.5 (-5.05%)

02/27/23 H.C. Wainwright
H.C. Wainwright reiterates Buy on PDS following positive FDA meeting
01/03/23 H.C. Wainwright
PDS Biotechnology price target raised to $21 from $15 at H.C. Wainwright
12/28/22 B. Riley
PDS Biotechnology price target raised to $12 from $10 at B. Riley
11/14/22 Chardan
PDS Biotechnology price target raised to $16 from $15 at Chardan
EFTR eFfector Therapeutics
$1.17 /

+0.13 (+12.50%)

05/26/23 Mizuho
eFfector Therapeutics posted positive breast cancer data, says Mizuho
05/26/23 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
ARAV Aravive
$1.80 /

+0.04 (+2.27%)

03/15/23 H.C. Wainwright
Aravive price target raised to $12 from $7 at H.C. Wainwright
01/04/23 EF Hutton
Aravive initiated with a Buy at EF Hutton
11/13/22 Piper Sandler
Aravive price target lowered to $2 from $6 at Piper Sandler
10/27/22 Roth MKM
Aravive price target lowered to $10 from $15 at Roth Capital
JNJ Johnson & Johnson
$156.98 /

+2.44 (+1.58%)

05/30/23 RBC Capital
Kenvue initiated with an Outperform at RBC Capital
05/30/23 Citi
Johnson & Johnson resumed with a Buy at Citi
05/30/23 JPMorgan
JPMorgan starts Kenvue with Overweight on 'resilient growth'
05/30/23 Goldman Sachs
Kenvue initiated with a Neutral at Goldman Sachs
BMY Bristol-Myers
$65.66 /

+0.98 (+1.52%)

05/01/23 Barclays
Bristol-Myers price target lowered to $65 from $66 at Barclays
04/28/23 Credit Suisse
Bristol-Myers price target lowered to $72 from $78 at Credit Suisse
04/21/23 BofA
Bristol-Myers price target raised to $85 from $82 at BofA
04/20/23 H.C. Wainwright
Legend Biotech price target raised to $77 from $66 at H.C. Wainwright
REGN Regeneron
$740.00 /

+8.995 (+1.23%)

05/19/23 Piper Sandler
Regeneron Q1 Eylea miss 'not about share, says Piper Sandler
05/08/23 Guggenheim
Regeneron price target lowered to $935 from $960 at Guggenheim
05/05/23 Morgan Stanley
Regeneron price target raised to $927 from $880 at Morgan Stanley
05/05/23 SVB Securities
Regeneron price target lowered to $895 from $976 at SVB Securities
GILD Gilead
$77.88 /

+1.665 (+2.18%)

06/02/23 Argus
Gilead continues to make regulatory progress, says Argus
05/16/23 BMO Capital
Gilead upgraded to Outperform from Market Perform at BMO Capital
04/28/23 Piper Sandler
Gilead assumed with an Overweight at Piper Sandler
04/12/23 Morgan Stanley
Gilead price target raised to $85 from $81 at Morgan Stanley
NVS Novartis
$98.90 /

+1.79 (+1.84%)

05/19/23 JPMorgan
JPMorgan places 'Negative Catalyst Watch' on Novartis into data
04/26/23 Barclays
Novartis price target raised to CHF 90 from CHF 85 at Barclays
04/26/23 Credit Suisse
Novartis price target raised to CHF 90 from CHF 80 at Credit Suisse
04/26/23 JPMorgan
Novartis price target raised to CHF 92 from CHF 85 at JPMorgan
MBIO Mustang Bio
$5.60 /

-0.71 (-11.25%)

05/26/23 B. Riley
Mustang Bio price target raised to $10 from $4 at B. Riley
11/16/22 BTIG
Mustang Bio price target lowered to $4 from $8 at BTIG
08/17/22 BTIG
Bluebird's approval has positive read for Mustang Bio, says BTIG
07/14/22 B. Riley
Mustang Bio price target lowered to $4 from $5 at B. Riley
REGN Regeneron
$740.00 /

+8.995 (+1.23%)

PDSB PDS Biotechnology
$9.40 /

-0.5 (-5.05%)

ONCY Oncolytics
$1.70 /

+0.05 (+3.03%)

NVS Novartis
$98.90 /

+1.79 (+1.84%)

MBIO Mustang Bio
$5.60 /

-0.71 (-11.25%)

JNJ Johnson & Johnson
$156.98 /

+2.44 (+1.58%)

GILD Gilead
$77.88 /

+1.665 (+2.18%)

EFTR eFfector Therapeutics
$1.17 /

+0.13 (+12.50%)

BMY Bristol-Myers
$65.66 /

+0.98 (+1.52%)

ARAV Aravive
$1.80 /

+0.04 (+2.27%)

REGN Regeneron
$740.00 /

+8.995 (+1.23%)

NVS Novartis
$98.90 /

+1.79 (+1.84%)

JNJ Johnson & Johnson
$156.98 /

+2.44 (+1.58%)

BMY Bristol-Myers
$65.66 /

+0.98 (+1.52%)

REGN Regeneron
$740.00 /

+8.995 (+1.23%)

PDSB PDS Biotechnology
$9.40 /

-0.5 (-5.05%)

NVS Novartis
$98.90 /

+1.79 (+1.84%)

JNJ Johnson & Johnson
$156.98 /

+2.44 (+1.58%)

IMAB I-Mab
$3.18 /

+0.145 (+4.78%)

GILD Gilead
$77.88 /

+1.665 (+2.18%)

EFTR eFfector Therapeutics
$1.17 /

+0.13 (+12.50%)

BMY Bristol-Myers
$65.66 /

+0.98 (+1.52%)

REGN Regeneron
$740.00 /

+8.995 (+1.23%)

PDSB PDS Biotechnology
$9.40 /

-0.5 (-5.05%)

NVS Novartis
$98.90 /

+1.79 (+1.84%)

JNJ Johnson & Johnson
$156.98 /

+2.44 (+1.58%)

GILD Gilead
$77.88 /

+1.665 (+2.18%)

BMY Bristol-Myers
$65.66 /

+0.98 (+1.52%)

Hot Stocks
Eli Lilly exec Jonsson sells 6,000 common shares » 16:34
06/02/23
06/02
16:34
06/02/23
16:34
LLY

Eli Lilly

$441.99 /

+5.515 (+1.26%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:34

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

05/26/23 Wells Fargo
Eli Lilly price target raised to $500 from $440 at Wells Fargo
05/24/23 BofA
Eli Lilly price target raised to $500 from $450 at BofA
05/23/23 TD Cowen
Eli Lilly price target raised to $500 from $430 at TD Cowen
05/19/23 JPMorgan
JPMorgan places 'Negative Catalyst Watch' on Novartis into data
LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

Conference/Events
Cantor Fitzgerald biotech to hold analyst/industry dinner meeting » 16:34
06/02/23
06/02
16:34
06/02/23
16:34
ASND

Ascendis Pharma

$91.27 /

+3.36 (+3.82%)

, ZYME

Zymeworks

$8.67 /

+0.18 (+2.12%)

, BCYC

Bicycle Therapeutics

$25.23 /

+1.105 (+4.58%)

, IOVA

Iovance Biotherapeutics

$8.80 /

+0.07 (+0.80%)

, KURA

Kura Oncology

$13.19 /

-0.3 (-2.22%)

, PFE

Pfizer

$38.36 /

+0.325 (+0.85%)

, ARVN

Arvinas

$23.24 /

+1.505 (+6.92%)

, RHHBY

Roche

$40.39 /

+0.42 (+1.05%)

, SNY

Sanofi

$51.01 /

+0.59 (+1.17%)

, AZN

AstraZeneca

$72.57 /

-0.27 (-0.37%)

, LLY

Eli Lilly

$441.99 /

+5.515 (+1.26%)

, ALXO

ALX Oncology

$8.34 /

+0.965 (+13.09%)

, PRTG

Portage Biotech

$3.64 /

-0.07 (-1.89%)

Biotech Analyst Watsek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:34

Get Free Trial

ShowHide Related Items >><<
ZYME Zymeworks
$8.67 /

+0.18 (+2.12%)

SNY Sanofi
$51.01 /

+0.59 (+1.17%)

RHHBY Roche
$40.39 /

+0.42 (+1.05%)

PFE Pfizer
$38.36 /

+0.325 (+0.85%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

KURA Kura Oncology
$13.19 /

-0.3 (-2.22%)

IOVA Iovance Biotherapeutics
$8.80 /

+0.07 (+0.80%)

BCYC Bicycle Therapeutics
$25.23 /

+1.105 (+4.58%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

ASND Ascendis Pharma
$91.27 /

+3.36 (+3.82%)

ARVN Arvinas
$23.24 /

+1.505 (+6.92%)

ALXO ALX Oncology
$8.34 /

+0.965 (+13.09%)

ASND Ascendis Pharma
$91.27 /

+3.36 (+3.82%)

06/02/23 Wedbush
Ascendis Pharma price target raised to $187 from $186 at Wedbush
05/08/23 Wedbush
Ascendis Pharma added to Best Ideas List at Wedbush
04/28/23 Cantor Fitzgerald
Ascendis Pharma price target raised to $152 from $142 at Cantor Fitzgerald
04/12/23 Morgan Stanley
Ascendis Pharma price target lowered to $107 from $108 at Morgan Stanley
ZYME Zymeworks
$8.67 /

+0.18 (+2.12%)

05/18/23 Citi
Zymeworks price target raised to $18 from $17 at Citi
05/09/23 Stifel
Zymeworks price target raised to $19 from $18 at Stifel
03/20/23 Wells Fargo
Zymeworks coverage transferred at Wells Fargo with Overweight rating
03/10/23 Citi
Zymeworks price target lowered to $17 from $21 at Citi
BCYC Bicycle Therapeutics
$25.23 /

+1.105 (+4.58%)

01/04/23 EF Hutton
Bicycle Therapeutics initiated with a Buy at EF Hutton
01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
11/10/22 Piper Sandler
Bicycle Therapeutics price target raised to $48 from $37 at Piper Sandler
11/09/22 JMP Securities
Bicycle Therapeutics price target lowered to $46 from $70 at JMP Securities
IOVA Iovance Biotherapeutics
$8.80 /

+0.07 (+0.80%)

05/30/23 Wells Fargo
Iovance upgraded to Overweight at Wells Fargo after lifileucel BLA accepted
05/30/23 Wells Fargo
Iovance Biotherapeutics upgraded to Overweight from Equal Weight at Wells Fargo
05/30/23 Stifel
Iovance Biotherapeutics price target raised to $24 from $21 at Stifel
05/29/23 Barclays
Iovance news 'important clearing event' for shares, says Barclays
KURA Kura Oncology
$13.19 /

-0.3 (-2.22%)

05/31/23 Barclays
Barclays reveals two small cap ideas into ASCO conference
05/16/23 BTIG
Kura Oncology initiated with a Buy at BTIG
05/11/23 Stifel
Kura Oncology price target lowered to $24 from $25 at Stifel
04/17/23 H.C. Wainwright
Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright
PFE Pfizer
$38.36 /

+0.325 (+0.85%)

05/23/23 Jefferies
Jefferies says Pfizer oral GLP-1 safety and tolerability 'important to note'
05/22/23
Pfizer weight loss drug may be as effective, quicker than Ozempic, CNBC says
05/19/23 BofA
AdComm support for Pfizer's infant RSV vaccine 'not surprising,' says BofA
05/16/23 Stifel
Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel
ARVN Arvinas
$23.24 /

+1.505 (+6.92%)

05/08/23 Stifel
Arvinas price target lowered to $72 from $75 at Stifel
03/18/23 Citi
Arvinas price target raised to $77 from $72 at Citi
02/23/23 Capital One
Arvinas remains one of the best biotechs to own, says Capital One
01/17/23 Truist
Arvinas price target lowered to $65 from $100 at Truist
RHHBY Roche
$40.39 /

+0.42 (+1.05%)

05/19/23 Piper Sandler
Regeneron Q1 Eylea miss 'not about share, says Piper Sandler
05/08/23 Guggenheim
Regeneron price target lowered to $935 from $960 at Guggenheim
04/10/23 BofA
BofA questions relevance of Briumvi tracking to Q1 beat, says TG move 'overdone'
03/27/23 Barclays
Roche downgraded to Equal Weight from Overweight at Barclays
SNY Sanofi
$51.01 /

+0.59 (+1.17%)

05/04/23 Raymond James
Kymera Therapeutics upgraded to Outperform from Market Perform at Raymond James
04/28/23 Deutsche Bank
Sanofi downgraded to Sell from Hold at Deutsche Bank
04/28/23 Deutsche Bank
Sanofi downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

05/26/23 Argus
AstraZeneca price target lowered to $80 from $85 at Argus
05/09/23 Berenberg
AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg
04/28/23 JPMorgan
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan
04/13/23 Argus
AstraZeneca price target raised to $85 from $75 at Argus
LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

05/26/23 Wells Fargo
Eli Lilly price target raised to $500 from $440 at Wells Fargo
05/24/23 BofA
Eli Lilly price target raised to $500 from $450 at BofA
05/23/23 TD Cowen
Eli Lilly price target raised to $500 from $430 at TD Cowen
05/19/23 JPMorgan
JPMorgan places 'Negative Catalyst Watch' on Novartis into data
ALXO ALX Oncology
$8.34 /

+0.965 (+13.09%)

03/14/23 UBS
ALX Oncology price target lowered to $29 from $31 at UBS
03/10/23 H.C. Wainwright
ALX Oncology price target lowered to $30 from $65 at H.C. Wainwright
11/09/22 Cantor Fitzgerald
ALX Oncology price target lowered to $22 from $32 at Cantor Fitzgerald
11/09/22 H.C. Wainwright
ALX Oncology price target lowered to $65 from $80 at H.C. Wainwright
PRTG Portage Biotech
$3.64 /

-0.07 (-1.89%)

12/01/22 H.C. Wainwright
Portage Biotech price target lowered to $21 from $22 at H.C. Wainwright
11/30/22 Cantor Fitzgerald
Portage Biotech price target lowered to $18 from $26 at Cantor Fitzgerald
11/30/22 Oppenheimer
Portage Biotech price target lowered to $18 from $26 at Oppenheimer
09/20/22 H.C. Wainwright
Portage Biotech price target lowered to $22 from $32 at H.C. Wainwright
ZYME Zymeworks
$8.67 /

+0.18 (+2.12%)

SNY Sanofi
$51.01 /

+0.59 (+1.17%)

RHHBY Roche
$40.39 /

+0.42 (+1.05%)

PRTG Portage Biotech
$3.64 /

-0.07 (-1.89%)

PFE Pfizer
$38.36 /

+0.325 (+0.85%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

KURA Kura Oncology
$13.19 /

-0.3 (-2.22%)

IOVA Iovance Biotherapeutics
$8.80 /

+0.07 (+0.80%)

BCYC Bicycle Therapeutics
$25.23 /

+1.105 (+4.58%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

ARVN Arvinas
$23.24 /

+1.505 (+6.92%)

ALXO ALX Oncology
$8.34 /

+0.965 (+13.09%)

SNY Sanofi
$51.01 /

+0.59 (+1.17%)

RHHBY Roche
$40.39 /

+0.42 (+1.05%)

PFE Pfizer
$38.36 /

+0.325 (+0.85%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

ZYME Zymeworks
$8.67 /

+0.18 (+2.12%)

SNY Sanofi
$51.01 /

+0.59 (+1.17%)

RHHBY Roche
$40.39 /

+0.42 (+1.05%)

PFE Pfizer
$38.36 /

+0.325 (+0.85%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

KURA Kura Oncology
$13.19 /

-0.3 (-2.22%)

IOVA Iovance Biotherapeutics
$8.80 /

+0.07 (+0.80%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

ASND Ascendis Pharma
$91.27 /

+3.36 (+3.82%)

PFE Pfizer
$38.36 /

+0.325 (+0.85%)

LLY Eli Lilly
$441.99 /

+5.515 (+1.26%)

AZN AstraZeneca
$72.57 /

-0.27 (-0.37%)

Hot Stocks
AstraZeneca's IMFINZI plus chemo improved pathologic response in Phase III trial » 15:57
06/02/23
06/02
15:57
06/02/23
15:57
AZN

AstraZeneca

$72.81 /

-0.03 (-0.04%)

Positive high-level…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 5th, 15:57

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$72.81 /

-0.03 (-0.04%)

AZN AstraZeneca
$72.81 /

-0.03 (-0.04%)

05/26/23 Argus
AstraZeneca price target lowered to $80 from $85 at Argus
05/09/23 Berenberg
AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg
04/28/23 JPMorgan
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan
04/13/23 Argus
AstraZeneca price target raised to $85 from $75 at Argus
AZN AstraZeneca
$72.81 /

-0.03 (-0.04%)

AZN AstraZeneca
$72.81 /

-0.03 (-0.04%)

AZN AstraZeneca
$72.81 /

-0.03 (-0.04%)

AZN AstraZeneca
$72.81 /

-0.03 (-0.04%)

Hot Stocks
AstraZeneca says Imfinzi plus chemotherapy showed clinical benefit in trial » 12:06
06/02/23
06/02
12:06
06/02/23
12:06
AZN

AstraZeneca

$73.22 /

+0.38 (+0.52%)

AstraZeneca reports…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 5th, 12:06

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$73.22 /

+0.38 (+0.52%)

AZN AstraZeneca
$73.22 /

+0.38 (+0.52%)

05/26/23 Argus
AstraZeneca price target lowered to $80 from $85 at Argus
05/09/23 Berenberg
AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg
04/28/23 JPMorgan
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan
04/13/23 Argus
AstraZeneca price target raised to $85 from $75 at Argus
AZN AstraZeneca
$73.22 /

+0.38 (+0.52%)

AZN AstraZeneca
$73.22 /

+0.38 (+0.52%)

AZN AstraZeneca
$73.22 /

+0.38 (+0.52%)

AZN AstraZeneca
$73.22 /

+0.38 (+0.52%)

Recommendations
Gilead continues to make regulatory progress, says Argus » 08:25
06/02/23
06/02
08:25
06/02/23
08:25
GILD

Gilead

$76.22 /

-0.735 (-0.96%)

Argus keeps a Buy rating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 5th, 08:25

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$76.22 /

-0.735 (-0.96%)

GILD Gilead
$76.22 /

-0.735 (-0.96%)

05/16/23 BMO Capital
Gilead upgraded to Outperform from Market Perform at BMO Capital
04/28/23 Piper Sandler
Gilead assumed with an Overweight at Piper Sandler
04/12/23 Morgan Stanley
Gilead price target raised to $85 from $81 at Morgan Stanley
04/05/23 Guggenheim
InflaRx upgraded to Buy at Guggenheim after Gohibic gets COVID EUA
GILD Gilead
$76.22 /

-0.735 (-0.96%)

GILD Gilead
$76.22 /

-0.735 (-0.96%)

GILD Gilead
$76.22 /

-0.735 (-0.96%)

Conference/Events
Oppenheimer biotech analyst to hold a reception » 04:55
06/02/23
06/02
04:55
06/02/23
04:55
AGEN

Agenus

$1.59 /

+0.04 (+2.58%)

, CGEN

Compugen

$1.01 /

-0.02 (-1.94%)

, DAWN

Day One Biopharmaceuticals

$13.65 /

+0.35 (+2.63%)

, ERAS

Erasca

$2.69 /

-0.025 (-0.92%)

, IMRX

Immuneering

$9.21 /

+1.54 (+20.08%)

, KNTE

Kinnate Biopharma

$4.32 /

+0.03 (+0.70%)

, MRTX

Mirati Therapeutics

$37.00 /

-0.14 (-0.38%)

, RVMD

Revolution Medicines

$25.19 /

+0.27 (+1.08%)

, VIRX

Viracta Therapeutics

$1.40 /

+0.08 (+6.06%)

, ONCT

Oncternal Therapeutics

/

+

, BMEA

Biomea Fusion

$35.63 /

+1.745 (+5.15%)

, MRNA

Moderna

$128.53 /

+0.93 (+0.73%)

, REGN

Regeneron

$731.21 /

-2.79 (-0.38%)

, AZN

AstraZeneca

$72.85 /

-0.22 (-0.30%)

, GILD

Gilead

$76.22 /

-0.735 (-0.96%)

, VSTM

Verastem

$11.83 /

-0.17 (-1.42%)

, SWTX

SpringsWorks Therapeutics

$27.63 /

+0.23 (+0.84%)

Biotech Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 5th, 04:55

Get Free Trial

ShowHide Related Items >><<
VSTM Verastem
$11.83 /

-0.17 (-1.42%)

VIRX Viracta Therapeutics
$1.40 /

+0.08 (+6.06%)

SWTX SpringsWorks Therapeutics
$27.63 /

+0.23 (+0.84%)

RVMD Revolution Medicines
$25.19 /

+0.27 (+1.08%)

REGN Regeneron
$731.21 /

-2.79 (-0.38%)

ONCT Oncternal Therapeutics
/

+

MRTX Mirati Therapeutics
$37.00 /

-0.14 (-0.38%)

MRNA Moderna
$128.53 /

+0.93 (+0.73%)

KNTE Kinnate Biopharma
$4.32 /

+0.03 (+0.70%)

IMRX Immuneering
$9.21 /

+1.54 (+20.08%)

GILD Gilead
$76.22 /

-0.735 (-0.96%)

ERAS Erasca
$2.69 /

-0.025 (-0.92%)

DAWN Day One Biopharmaceuticals
$13.65 /

+0.35 (+2.63%)

CGEN Compugen
$1.01 /

-0.02 (-1.94%)

BMEA Biomea Fusion
$35.63 /

+1.745 (+5.15%)

AZN AstraZeneca
$72.85 /

-0.22 (-0.30%)

AGEN Agenus
$1.59 /

+0.04 (+2.58%)

AGEN Agenus
$1.59 /

+0.04 (+2.58%)

05/25/23 EF Hutton
Agenus assumed with a Buy at EF Hutton
05/09/23 H.C. Wainwright
Agenus's progress continues with data presentations, says H.C. Wainwright
04/20/23 B. Riley
B. Riley came away 'encouraged' on Agenus after AACR
02/28/23 H.C. Wainwright
Agenus assumed with a Buy at H.C. Wainwright
CGEN Compugen
$1.01 /

-0.02 (-1.94%)

02/08/23 Jefferies
Compugen downgraded to Underperform from Hold at Jefferies
01/04/23 EF Hutton
Compugen initiated with a Buy at EF Hutton
11/14/22 Oppenheimer
Compugen price target lowered to $8 from $12 at Oppenheimer
08/23/22 Truist
Compugen price target lowered to $4 from $14 at Truist
DAWN Day One Biopharmaceuticals
$13.65 /

+0.35 (+2.63%)

05/01/23 Oppenheimer
Day One language around NDA submission 'sounded ominous,' says Oppenheimer
05/01/23 H.C. Wainwright
Day One pullback brings attractive entry point, says H.C. Wainwright
04/25/23 BofA
Day One Biopharmaceuticals double downgraded at BofA on regulatory risks
04/25/23 BofA
Day One Biopharmaceuticals downgraded to Underperform from Buy at BofA
ERAS Erasca
$2.69 /

-0.025 (-0.92%)

03/29/23 Mizuho
Erasca initiated with a Buy at Mizuho
02/24/23 Goldman Sachs
Erasca initiated with a Buy at Goldman Sachs
02/03/23 Morgan Stanley
Erasca upgraded to Overweight from Equal Weight at Morgan Stanley
IMRX Immuneering
$9.21 /

+1.54 (+20.08%)

04/19/23 Mizuho
Immuneering upgraded to Buy from Neutral at Mizuho
04/19/23 Morgan Stanley
Immuneering upgraded to Equal Weight from Underweight at Morgan Stanley
04/18/23 Chardan
Immuneering price target raised to $22 from $18 at Chardan
03/29/23 Mizuho
Immuneering initiated with a Neutral at Mizuho
KNTE Kinnate Biopharma
$4.32 /

+0.03 (+0.70%)

05/18/23 H.C. Wainwright
Kinnate Biopharma price target lowered to $24 from $25 at H.C. Wainwright
04/20/23 H.C. Wainwright
Kinnate Biopharma price target lowered to $25 from $33 at H.C. Wainwright
04/18/23 Stifel
Kinnate Biopharma price target lowered to $5 from $8 at Stifel
04/18/23 Wedbush
Kinnate Biopharma price target lowered to $14 from $25 at Wedbush
MRTX Mirati Therapeutics
$37.00 /

-0.14 (-0.38%)

05/25/23 Oppenheimer
Oppenheimer upgrades Mirati to Outperform with Krazati expectations reset
05/25/23 Oppenheimer
Mirati Therapeutics upgraded to Outperform from Perform at Oppenheimer
05/25/23 BMO Capital
Mirati Therapeutics price target lowered to $40 from $50 at BMO Capital
05/25/23 Barclays
Mirati Therapeutics price target lowered to $75 from $90 at Barclays
RVMD Revolution Medicines
$25.19 /

+0.27 (+1.08%)

05/09/23 JPMorgan
Revolution Medicines price target lowered to $35 from $38 at JPMorgan
02/28/23 Needham
Revolution Medicines price target raised to $38 from $32 at Needham
02/28/23 Oppenheimer
Revolution Medicines price target raised to $35 from $30 at Oppenheimer
02/28/23 JPMorgan
Revolution Medicines upgraded to Overweight from Neutral at JPMorgan
VIRX Viracta Therapeutics
$1.40 /

+0.08 (+6.06%)

05/10/23 H.C. Wainwright
Viracta Therapeutics price target lowered to $33 from $35 at H.C. Wainwright
ONCT Oncternal Therapeutics
/

+

04/06/23 Cantor Fitzgerald
Oncternal downgraded to Neutral from Overweight at Cantor Fitzgerald
04/04/23 Maxim
Oncternal Therapeutics downgraded to Hold from Buy at Maxim
04/04/23 Cantor Fitzgerald
Oncternal Therapeutics price target lowered to $1.30 from $4.00 at Cantor Fitzgerald
04/04/23 H.C. Wainwright
Oncternal Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
BMEA Biomea Fusion
$35.63 /

+1.745 (+5.15%)

05/25/23 EF Hutton
Biomea Fusion assumed with a Buy at EF Hutton
05/18/23 Citi
Biomea Fusion price target lowered to $53 from $55 at Citi
05/12/23 Barclays
Biomea Fusion initiated with an Overweight at Barclays
04/19/23 H.C. Wainwright
Biomea Fusion price target lowered to $37 from $44 at H.C. Wainwright
MRNA Moderna
$128.53 /

+0.93 (+0.73%)

05/31/23 Jefferies
Carisma Therapeutics assumed at Buy from Hold at Jefferies
05/05/23 Morgan Stanley
Moderna price target lowered to $153 from $185 at Morgan Stanley
04/25/23 Guggenheim
Moderna initiated with a Neutral at Guggenheim
04/13/23 Baird
Carisma Therapeutics initiated with an Outperform at Baird
REGN Regeneron
$731.21 /

-2.79 (-0.38%)

05/19/23 Piper Sandler
Regeneron Q1 Eylea miss 'not about share, says Piper Sandler
05/08/23 Guggenheim
Regeneron price target lowered to $935 from $960 at Guggenheim
05/05/23 Morgan Stanley
Regeneron price target raised to $927 from $880 at Morgan Stanley
05/05/23 SVB Securities
Regeneron price target lowered to $895 from $976 at SVB Securities
AZN AstraZeneca
$72.85 /

-0.22 (-0.30%)

05/26/23 Argus
AstraZeneca price target lowered to $80 from $85 at Argus
05/09/23 Berenberg
AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg
04/28/23 JPMorgan
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan
04/13/23 Argus
AstraZeneca price target raised to $85 from $75 at Argus
GILD Gilead
$76.22 /

-0.735 (-0.96%)

05/16/23 BMO Capital
Gilead upgraded to Outperform from Market Perform at BMO Capital
04/28/23 Piper Sandler
Gilead assumed with an Overweight at Piper Sandler
04/12/23 Morgan Stanley
Gilead price target raised to $85 from $81 at Morgan Stanley
04/05/23 Guggenheim
InflaRx upgraded to Buy at Guggenheim after Gohibic gets COVID EUA
VSTM Verastem
$11.83 /

-0.17 (-1.42%)

05/10/23 H.C. Wainwright
Verastem price target lowered to $2 from $3 at H.C. Wainwright
03/29/23 Mizuho
Verastem initiated with a Neutral at Mizuho
11/07/22 H.C. Wainwright
Verastem price target lowered to $3 from $5 at H.C. Wainwright
10/05/22 BTIG
Verastem price target lowered to $5 from $8 at BTIG
SWTX SpringsWorks Therapeutics
$27.63 /

+0.23 (+0.84%)

04/28/23 Barclays
SpringsWorks Therapeutics price target lowered to $41 from $55 at Barclays
03/07/23 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $105 from $99 at H.C. Wainwright
01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
12/01/22 BofA
SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA
VSTM Verastem
$11.83 /

-0.17 (-1.42%)

VIRX Viracta Therapeutics
$1.40 /

+0.08 (+6.06%)

SWTX SpringsWorks Therapeutics
$27.63 /

+0.23 (+0.84%)

RVMD Revolution Medicines
$25.19 /

+0.27 (+1.08%)

REGN Regeneron
$731.21 /

-2.79 (-0.38%)

ONCT Oncternal Therapeutics
/

+

MRTX Mirati Therapeutics
$37.00 /

-0.14 (-0.38%)

MRNA Moderna
$128.53 /

+0.93 (+0.73%)

KNTE Kinnate Biopharma
$4.32 /

+0.03 (+0.70%)

GILD Gilead
$76.22 /

-0.735 (-0.96%)

ERAS Erasca
$2.69 /

-0.025 (-0.92%)

DAWN Day One Biopharmaceuticals
$13.65 /

+0.35 (+2.63%)

CGEN Compugen
$1.01 /

-0.02 (-1.94%)

BMEA Biomea Fusion
$35.63 /

+1.745 (+5.15%)

AZN AstraZeneca
$72.85 /

-0.22 (-0.30%)

AGEN Agenus
$1.59 /

+0.04 (+2.58%)

  • 18
    Apr
  • 30
    Mar
  • 03
    Mar
  • 09
    Dec
  • 20
    Jul
  • 15
    Jun
REGN Regeneron
$731.21 /

-2.79 (-0.38%)

MRTX Mirati Therapeutics
$37.00 /

-0.14 (-0.38%)

MRNA Moderna
$128.53 /

+0.93 (+0.73%)

AZN AstraZeneca
$72.85 /

-0.22 (-0.30%)

VSTM Verastem
$11.83 /

-0.17 (-1.42%)

SWTX SpringsWorks Therapeutics
$27.63 /

+0.23 (+0.84%)

RVMD Revolution Medicines
$25.19 /

+0.27 (+1.08%)

REGN Regeneron
$731.21 /

-2.79 (-0.38%)

ONCT Oncternal Therapeutics
/

+

MRTX Mirati Therapeutics
$37.00 /

-0.14 (-0.38%)

MRNA Moderna
$128.53 /

+0.93 (+0.73%)

KNTE Kinnate Biopharma
$4.32 /

+0.03 (+0.70%)

GILD Gilead
$76.22 /

-0.735 (-0.96%)

ERAS Erasca
$2.69 /

-0.025 (-0.92%)

DAWN Day One Biopharmaceuticals
$13.65 /

+0.35 (+2.63%)

BMEA Biomea Fusion
$35.63 /

+1.745 (+5.15%)

AZN AstraZeneca
$72.85 /

-0.22 (-0.30%)

AGEN Agenus
$1.59 /

+0.04 (+2.58%)

REGN Regeneron
$731.21 /

-2.79 (-0.38%)

MRNA Moderna
$128.53 /

+0.93 (+0.73%)

GILD Gilead
$76.22 /

-0.735 (-0.96%)

BMEA Biomea Fusion
$35.63 /

+1.745 (+5.15%)

AZN AstraZeneca
$72.85 /

-0.22 (-0.30%)

Thursday
Initiation
Ambrx Biopharma initiated with an Outperform at Oppenheimer » 16:15
06/01/23
06/01
16:15
06/01/23
16:15
AMAM

Ambrx Biopharma

$14.52 /

-0.22 (-1.49%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMAM Ambrx Biopharma
$14.52 /

-0.22 (-1.49%)

AMAM Ambrx Biopharma
$14.52 /

-0.22 (-1.49%)

05/19/23 Cantor Fitzgerald
Ambrx Biopharma initiated with an Overweight at Cantor Fitzgerald
05/19/23 Cantor Fitzgerald
Ambrx Biopharma initiated with an Overweight at Cantor Fitzgerald
04/05/23 Baird
Ambrx Biopharma price target raised to $12 from $11 at Baird
03/03/23 Baird
Ambrx Biopharma price target raised to $11 from $4 at Baird
AMAM Ambrx Biopharma
$14.52 /

-0.22 (-1.49%)

AMAM Ambrx Biopharma
$14.52 /

-0.22 (-1.49%)

Hot Stocks
AstraZeneca, Merck announce LYNPARZA + abiraterone approved for BRCAm cancer » 07:15
06/01/23
06/01
07:15
06/01/23
07:15
AZN

AstraZeneca

$73.07 /

+1.64 (+2.30%)

, MRK

Merck

$110.45 /

+1.23 (+1.13%)

AstraZeneca (AZN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$110.45 /

+1.23 (+1.13%)

AZN AstraZeneca
$73.07 /

+1.64 (+2.30%)

AZN AstraZeneca
$73.07 /

+1.64 (+2.30%)

05/26/23 Argus
AstraZeneca price target lowered to $80 from $85 at Argus
05/09/23 Berenberg
AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg
04/28/23 JPMorgan
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan
04/13/23 Argus
AstraZeneca price target raised to $85 from $75 at Argus
MRK Merck
$110.45 /

+1.23 (+1.13%)

05/10/23 Jefferies
Prometheus downgraded to Hold from Buy at Jefferies
05/01/23 Barclays
Merck price target raised to $130 from $128 at Barclays
04/18/23 Wells Fargo
Prometheus downgraded to Equal Weight from Overweight at Wells Fargo
04/18/23 RBC Capital
Prometheus downgraded to Sector Perform from Outperform at RBC Capital
MRK Merck
$110.45 /

+1.23 (+1.13%)

AZN AstraZeneca
$73.07 /

+1.64 (+2.30%)

MRK Merck
$110.45 /

+1.23 (+1.13%)

AZN AstraZeneca
$73.07 /

+1.64 (+2.30%)

MRK Merck
$110.45 /

+1.23 (+1.13%)

AZN AstraZeneca
$73.07 /

+1.64 (+2.30%)

MRK Merck
$110.45 /

+1.23 (+1.13%)

AZN AstraZeneca
$73.07 /

+1.64 (+2.30%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.